Annual Cash & Cash Equivalents
$4.17 M
+$1.69 M+68.02%
June 30, 2024
Summary
- As of February 10, 2025, ESLAW annual cash & cash equivalents is $4.17 million, with the most recent change of +$1.69 million (+68.02%) on June 30, 2024.
- During the last 3 years, ESLAW annual cash & cash equivalents has risen by +$4.17 million (+100.00%).
Performance
ESLAW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.80 M
-$2.37 M-56.85%
September 30, 2024
Summary
- As of February 10, 2025, ESLAW quarterly cash and cash equivalents is $1.80 million, with the most recent change of -$2.37 million (-56.85%) on September 30, 2024.
- Over the past year, ESLAW quarterly cash and cash equivalents has dropped by -$7.25 million (-80.13%).
Performance
ESLAW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ESLAW Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.0% | -80.1% |
| 3 y3 years | +100.0% | -80.1% |
| 5 y5 years | +100.0% | -80.1% |
ESLAW Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -91.9% | at low |
| 5 y | 5-year | at high | -100.0% | -91.9% | at low |
| alltime | all time | at high | -100.0% | -91.9% | at low |
Estrella Immunopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.80 M(-56.8%) |
| Jun 2024 | $4.17 M | $4.17 M(-11.9%) |
| Mar 2024 | - | $4.73 M(-47.7%) |
| Dec 2023 | - | $9.05 M(-59.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $22.14 M(+668.7%) |
| Jun 2023 | $2.48 M(-39.4%) | - |
| Dec 2022 | - | $2.88 M |
| Jun 2022 | $4.09 M(>+9900.0%) | - |
| Jun 2021 | $0.00 | - |
FAQ
- What is Estrella Immunopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Estrella Immunopharma?
- What is Estrella Immunopharma annual cash & cash equivalents year-on-year change?
- What is Estrella Immunopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly cash and cash equivalents year-on-year change?
What is Estrella Immunopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of ESLAW is $4.17 M
What is the all time high annual cash & cash equivalents for Estrella Immunopharma?
Estrella Immunopharma all-time high annual cash & cash equivalents is $4.17 M
What is Estrella Immunopharma annual cash & cash equivalents year-on-year change?
Over the past year, ESLAW annual cash & cash equivalents has changed by +$1.69 M (+68.02%)
What is Estrella Immunopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ESLAW is $1.80 M
What is the all time high quarterly cash and cash equivalents for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly cash and cash equivalents is $22.14 M
What is Estrella Immunopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, ESLAW quarterly cash and cash equivalents has changed by -$7.25 M (-80.13%)